215 related articles for article (PubMed ID: 36647090)
1. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
Wei H; Ren J; Li R; Qi X; Yang F; Li Q
Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
[TBL] [Abstract][Full Text] [Related]
3. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
[TBL] [Abstract][Full Text] [Related]
4. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
[TBL] [Abstract][Full Text] [Related]
5. The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019.
Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y
Diabetes Metab Syndr; 2024 May; 18(5):103025. PubMed ID: 38851022
[TBL] [Abstract][Full Text] [Related]
6. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
[TBL] [Abstract][Full Text] [Related]
7. Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.
Wang M; Liu J; Yan L; Wang J; Jin Y; Zheng ZJ
J Nutr Health Aging; 2024 May; 28(6):100261. PubMed ID: 38810511
[TBL] [Abstract][Full Text] [Related]
8. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
[TBL] [Abstract][Full Text] [Related]
9. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
[TBL] [Abstract][Full Text] [Related]
10. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019.
Li C; Hua G; Liu S; Yu H; Yang X; Liu L
Diabetes Metab Res Rev; 2024 May; 40(4):e3802. PubMed ID: 38634501
[TBL] [Abstract][Full Text] [Related]
11. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control.
Bian Q; Zhang Y; Xue C; Lu W; Li W; Pan F; Li Y
BMC Public Health; 2024 Mar; 24(1):782. PubMed ID: 38481192
[TBL] [Abstract][Full Text] [Related]
12. Global Burden and Trends of Primary Liver Cancer Attributable to Comorbid Type 2 Diabetes Mellitus Among People Living with Hepatitis B: An Observational Trend Study from 1990 to 2019.
Xie J; Lin X; Fan X; Wang X; Pan D; Li J; Hao Y; Jie Y; Zhang L; Gu J
J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38713342
[TBL] [Abstract][Full Text] [Related]
13. Estimates of bladder cancer burden attributable to high fasting plasma glucose: Findings of the Global Burden of Disease Study 2019.
Wu Y; Deng Y; Dai Z; Ma Y; Lyu L; Lei C; Zheng Y; Li Y; Wang Z; Gao J
Cancer Med; 2023 Aug; 12(15):16469-16481. PubMed ID: 37350559
[TBL] [Abstract][Full Text] [Related]
14. Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990-2019: a systematic analysis for the GBD 2019.
Pang J; Chen K; Chen S; Chen X
Diabetol Metab Syndr; 2022 Aug; 14(1):112. PubMed ID: 35941673
[TBL] [Abstract][Full Text] [Related]
15. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.
Xie J; Liu Z; Ren L; He L; Lu S; Meng X; Zhang X; Su Z; Jing S; Shan T; Wang J; Xia R; Feng W; Li Y; Liu N; Liu Y
BMC Public Health; 2023 Jul; 23(1):1361. PubMed ID: 37454041
[TBL] [Abstract][Full Text] [Related]
16. Global, regional, and national burdens of hypertensive heart disease from 1990 to 2019 ：A multilevel analysis based on the global burden of Disease Study 2019.
Hu B; Shi Y; Zhang P; Fan Y; Feng J; Hou L
Heliyon; 2023 Dec; 9(12):e22671. PubMed ID: 38213586
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019.
Wang M; Liu J; Wang J; Jin Y; Zheng ZJ
J Diabetes; 2024 Mar; 16(3):e13499. PubMed ID: 38009553
[TBL] [Abstract][Full Text] [Related]
18. The Global Burden of Disease attributable to low physical activity and its trends from 1990 to 2019: An analysis of the Global Burden of Disease study.
Xu YY; Xie J; Yin H; Yang FF; Ma CM; Yang BY; Wan R; Guo B; Chen LD; Li SL
Front Public Health; 2022; 10():1018866. PubMed ID: 36590002
[TBL] [Abstract][Full Text] [Related]
19. The global burden of ischemic heart disease attributed to high fasting plasma glucose: Data from 1990 to 2019.
Shen N; Liu J; Wang Y; Qiu Y; Li D; Wang Q; Chai L; Chen Y; Hu H; Li M
Heliyon; 2024 Mar; 10(5):e27065. PubMed ID: 38495138
[TBL] [Abstract][Full Text] [Related]
20. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
Ke C; Liang J; Liu M; Liu S; Wang C
BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
